Press releases

QuantomiX and M&S Sign Exclusive Distribution Agreement for WETSEM^TM in Japan

Rehovot, Israel, November 22, 2004 - QuantomiX Ltd., producer of a unique line of capsules which enable imaging of wet samples with scanning electron microscopes (SEMs), has signed an exclusive distribution agreement for Japan with M&S Instruments Trading Inc. of Osaka, Japan. M&S, which distributes laboratory products, plans to market the capsules to Japanese SEM users for a wide range of applications.

The QX capsules based on QuantomiX proprietary WETSEM^TM technology, permit the user to view samples in a SEM without the need to freeze or dehydrate the samples. Viewing samples in their original state is a time and cost-saver, as well as being a breakthrough in imaging capabilities for the biological science, pharmaceutical, and health care industries.

"M&S is a highly specialized distributor of laboratory products, which fits QuantomiX target market perfectly," clarifies Dr. Ory Zik, founder and CEO of QuantomiX. "The Japanese market has the largest installed base of SEMs in the world, and we look forward to extensive sales of QX capsules in Japan within the coming five years."

M&S concurs with this prediction. Its Managing Director, Mr.Hiroyuki Sakanishi states, "We see QuantomiX capsules as the stepping stone towards more use of SEM for varied applications in many different markets, and we are poised to meet those needs."

Ariel Frischoff, Senior Project Manager of Triangle Technologies, which negotiated the deal, explains that the SEM market in Japan is a linchpin of the worldwide market. "Most of the leading SEM makers in the world are Japanese, and we anticipate forming special marketing relationships with these partners." QuantomiX also foresees that its capsules will help SEM makers expand the applications that their customers can use, thus increasing SEM sales. Discussions with several of the world´s leading SEM makers are already in advanced stages.

About QuantomiX

QuantomiX Ltd. (www.quantomix.com)  develops and commercializes breakthrough solutions based on its proprietary WETSEM^TM technology. This technology enables scanning electron microscopes (SEM) to image and analyze wet samples, including cells, tissue biopsies, foods and ink, in their native environment. Eliminating the need for time-consuming preparation procedures, the WETSEM^TM technology ensures that sample integrity is not compromised by artifacts. QuantomiX breakthrough technology opens new opportunities for application-specific tools to improve drug discovery, and advances treatment and diagnostic solutions for the medical and pharmaceutical markets.

Established in 2001, QuantomiX operates in Israel, the US, Europe and Japan. The company's managerial team and development staff include an experienced cadre of business and industry professionals.

QuantomiX is a privately held venture-backed company whose major investors include Pitango Venture Capital, Evergreen, VitaLife, and SFKT.

About M&S Instruments Trading

M&S Instruments Trading Ltd. (www.technosaurus.co.jp) is based in Osaka with an office in Tokyo. M&S has 65 employees, $25 million in annual revenues, and specializes in analytical instruments and consumable products for the life sciences market. M&S main customers include leading universities, research institutes and pharmaceutical companies throughout Japan. M&S works with a network of national and regional dealers in Japan.

About Triangle Technologies

Triangle Technologies Ltd. (www.triangletech.com) is based in Ramat-Gan and Tokyo and specializes in helping non-Japanese technology companies initiate or expand their business in Japan. Founded in 1990 by Dr. Daniel Isenberg, formerly on the faculty of the Harvard Business School, Triangle Technologies has executed over 60 projects resulting in over 100 transactions worth in excess of $400 million. Triangle Technologies' clients include Given Imaging, Optibase, Nur Macroprinters, Glucon Medical, QuantomiX, Discretix, Exanet, Extricom, BigBand Networks, Metrolight, Cyota, Voltaire, Radioscape, Xmpie, Topspin Medical, and numerous leading venture-backed companies.